Shionogi of Japan to Take Control of China’s C&O Pharma

Shionogi & Co., a Japanese pharma, will pay $185 million to obtain a controlling interest in C&O Pharmaceutical Technology. C&O Pharma, a company that produces antibiotics and other drugs for the China market, is headquartered in Hong Kong, but listed in Singapore. Shionogi said it wants to establish a major presence in China for its own drugs. More details.... Stock Symbol: (TO: 8053)     Share this with colleagues: